RX.V · BioSyent Inc.
Canada · RS rating 84 · As of 2026-10-14
| Price | 15.89 CAD |
|---|---|
| 1-day change | -0.5% |
| RS rating (overall / 1M / 3M / 12M) | 84 / 65 / 80 / 81 |
| Stage | Topping |
| Composite / Minervini / CANSLIM score | 53 / 54 / 67 |
| Industry group (rank) | Medical-Generic Drugs (45) |
| EPS growth Q/Q | +21.3% |
| Sales growth Q/Q | +42.9% |
| Distance from 52-week high | +9.2% |
| Market cap (USD) | $135.4M |